Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Hege Oma Ohnstad"'
Autor:
Abhibhav Sharma, Julia Debik, Bjørn Naume, Hege Oma Ohnstad, Oslo Breast Cancer Consortium (OSBREAC), Tone F. Bathen, Guro F. Giskeødegård
Publikováno v:
Oncogenesis, Vol 13, Iss 1, Pp 1-13 (2024)
Abstract Breast cancer (BC) is a leading cause of cancer-related death worldwide. The diverse nature and heterogeneous biology of BC pose challenges for survival prediction, as patients with similar diagnoses often respond differently to treatment. C
Externí odkaz:
https://doaj.org/article/11d3e2fb5e8e44b79e82cb05230e5944
Autor:
Xavier Tekpli, Tonje Lien, Andreas Hagen Røssevold, Daniel Nebdal, Elin Borgen, Hege Oma Ohnstad, Jon Amund Kyte, Johan Vallon-Christersson, Marie Fongaard, Eldri Undlien Due, Lisa Gregusson Svartdal, My Anh Tu Sveli, Øystein Garred, OSBREAC, Arnoldo Frigessi, Kristine Kleivi Sahlberg, Therese Sørlie, Hege G. Russnes, Bjørn Naume, Vessela N. Kristensen
Publikováno v:
Nature Communications, Vol 10, Iss 1, Pp 1-14 (2019)
In breast cancer, the immune infiltration of the tumour associates with clinical outcome. Here, the authors infer immune context based on gene expression data and identify a new independent subtype linked to pro-tumorigenic immune infiltration.
Externí odkaz:
https://doaj.org/article/77641556908e44e9aa2cd197f5b2e87b
Autor:
Mona-Elisabeth, Revheim, Therese, Seierstad, Jeanne-Marie, Berner, Oyvind Sverre, Bruland, Kathrine, Røe, Hege Oma, Ohnstad, Bodil, Bjerkehagen, Tore, Bach-Gansmo
Publikováno v:
Anticancer research. 29(11)
The majority of gastrointestinal stromal tumours (GISTs) contain oncogenic KIT (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog) or platelet-derived growth factor-alpha (PDGFRA) receptor tyrosine kinase (TK) mutations and are initially,
Publikováno v:
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke. 125(4)
In spite of increased knowledge in palliative care, there are still cancer patients who do not receive adequate pain relief. There is limited information on cancer pain experience in Norwegian hospitals. More data is needed in order to understand why